Genmab — Januar 2019
-
De havde nok ikke nævnt det hvis ikke de var sikre på at få godkendelsen. Tror den kommer snart (som nævnt tidligere). Her kan man se SGEN's pressemeddelelser fra 15 og 16 november http://investor.seattlegenetics.com/press-releases
-
JNJ also mentioning it, so it is coördinated https://twitter.com/JanssenUS/status/1087786280761655297
-
Fra JnJ CC transscript om Darzalex: U.S. grew 34% and continues to benefit from strong market growth and a 6-point increase in U.S. market share across all lines of therapy based on third quarter data. - Det tolker jeg som at dara har snuppet 6 %-point markedsandel i US.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
